Urine Potassium Excretion, Kidney Failure, and Mortality in CKD

American Journal of Kidney Diseases

Volumn 69, Issue 3, 2017, Pages 341-349

  Leonberg Yoo, Amanda K ^a   Tighiouart, Hocine ^a   Levey, Andrew S ^a   Beck, Gerald J ^b   Sarnak, Mark J ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

all cause mortality; chronic kidney disease (CKD); dietary potassium intake; end stage renal disease (ESRD); kidney failure; modifiable risk factor; potassium excretion; Urine potassium

Indexed keywords

CREATININE; POTASSIUM;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; POTASSIUM EXCRETION; POTASSIUM INTAKE; POTASSIUM URINE LEVEL; PROSPECTIVE STUDY; PROTEIN INTAKE; PROTEIN RESTRICTION; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; COMPLICATION; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY; URINE;

COHORT STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POTASSIUM; RENAL INSUFFICIENCY; RENAL INSUFFICIENCY, CHRONIC;

EID: 84973895585     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2016.03.431     Document Type: Article

References (29)

1. 1 American Heart Association Nutrition Committee, Lichtenstein, A.H., Appel, L.J., Brands, M., Carnethon, M., Daniels, S., et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114:1 (2006), 82–96.
2. 2 Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Inter Suppl 2 (2012), 337–414.
3. 3 Drewnowski, A., Rehm, C.D., Maillot, M., Mendoza, A., Monsivais, P., The feasibility of meeting the WHO guidelines for sodium and potassium: a cross-national comparison study. BMJ Open, 5(3), 2015, e006625.
4. 4 National Kidney Foundation. KDOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis, 43(5 suppl 1), 2004 65-230.
5. 5 No authors listed. Chapter 2: lifestyle and pharmacological treatments for lowering blood pressure in CKD ND patients. Kidney Int Suppl 2:5 (2011), 347–356.
6. 6 Kieneker, L.M., Gansevoort, R.T., Mukamal, K.J., et al. Urinary potassium excretion and risk of developing hypertension: the Prevention of Renal and Vascular End-Stage Disease Study. Hypertension 64:4 (2014), 769–776.
7. 7 Stamler J. The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr. 1997;65(2 suppl): 626S-642S.
8. 8 Mente, A., O'Donnell, M.J., Rangarajan, S., et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med 371:7 (2014), 601–611.
9. 9 O'Donnell, M., Mente, A., Rangarajan, S., et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 371:7 (2014), 612–623.
10. 10 Aburto, N.J., Hanson, S., Gutierrez, H., Hooper, L., Elliott, P., Cappuccio, F.P., Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ, 346, 2013, f1378.
11. 11 Cook, N.R., Obarzanek, E., Cutler, J.A., et al. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med 169:1 (2009), 32–40.
12. 12 Houston, M.C., The importance of potassium in managing hypertension. Curr Hypertens Rep 13:4 (2011), 309–317.
13. 13 Whelton, P.K., He, J., Cutler, J.A., et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 277:20 (1997), 1624–1632.
14. 14 He, F.J., Marciniak, M., Carney, C., et al. Effects of potassium chloride and potassium bicarbonate on endothelial function, cardiovascular risk factors, and bone turnover in mild hypertensives. Hypertension 55:3 (2010), 681–688.
15. 15 Sharma, S., McFann, K., Chonchol, M., de Boer, I.H., Kendrick, J., Association between dietary sodium and potassium intake with chronic kidney disease in US adults: a cross-sectional study. Am J Nephrol 37:6 (2013), 526–533.
16. 16 Smyth, A., Dunkler, D., Gao, P., et al. The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney Int 86:6 (2014), 1205–1212.
17. 17 He, J., Mills, K.T., Appel, L.J., et al. Urinary sodium and potassium excretion and CKD progression. J Am Soc Nephrol 27:4 (2016), 1202–1212.
18. 18 Araki, S., Haneda, M., Koya, D., et al. Urinary potassium excretion and renal and cardiovascular complications in patients with type 2 diabetes and normal renal function. Clin J Am Soc Nephrol 10:12 (2015), 2152–2158.
19. 19 Klahr, S., Levey, A.S., Beck, G.J., et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:13 (1994), 877–884.
20. 20 Ix, J.H., Wassel, C.L., Stevens, L.A., et al. Equations to estimate creatinine excretion rate: the CKD Epidemiology Collaboration. Clin J Am Soc Nephrol 6:1 (2011), 184–191.
21. 21 Peterson, J.C., Adler, S., Burkart, J.M., et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123:10 (1995), 754–762.
22. 22 Adrogue, H.J., Madias, N.E., Sodium surfeit and potassium deficit: keys to the pathogenesis of hypertension. J Am Soc Hypertens 8:3 (2014), 203–213.
23. 23 Lin, H.B., Young, D.B., Smith, M.J. Jr., Stimulation of renin release by hyperkalemia in the nonfiltering kidney. Am J Physiol 260:2, pt 2 (1991), F170–F176.
24. 24 Katori, M., Majima, M., The renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension. Crit Rev Clin Lab Sci 40:1 (2003), 43–115.
25. 25 Meneton, P., Jeunemaitre, X., de Wardener, H.E., MacGregor, G.A., Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 85:2 (2005), 679–715.
26. 26 Holbrook, J.T., Patterson, K.Y., Bodner, J.E., et al. Sodium and potassium intake and balance in adults consuming self-selected diets. Am J Clin Nutr 40:4 (1984), 786–793.
27. 27 van Ypersele de Strihou, C., Potassium homeostasis in renal failure. Kidney Int 11:6 (1977), 491–504.
28. 28 Kopple, J.D., Coburn, J.W., Metabolic studies of low protein diets in uremia. I. Nitrogen and potassium. Medicine (Baltimore) 52:6 (1973), 583–595.
29. 29 Kahn, T., Kaji, D.M., Nicolis, G., Krakoff, L.R., Stein, R.M., Factors related to potassium transport in chronic stable renal disease in man. Clin Sci Mol Med 54:6 (1978), 661–666.